Nuvectis Pharma Inc share price logo

Nuvectis Pharma Inc

NASDAQ: NVCT

Small Cap

$8.55

+0.05

(+0.59%)

as on

Nuvectis Pharma Inc Stock Performance

as on May 1, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $8.42
    $8.64
    downward going graph

    1.52%

    Downside

    1.05%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.55
    $11.15
    downward going graph

    35.09%

    Downside

    30.41%

    Upside

    downward going graph

Nuvectis Pharma Inc share price movements today

Previous Close
$8.50
Open
$8.50
Volume
211.0K
Day's Low - High
$8.42 - $8.64
52 Week Low - High
$5.55 - $11.15

Nuvectis Pharma Inc Historical Returns

1 Month Return
+ 13.48 %
3 Month Return
+ 4.81 %
1 Year Return
-14.66 %
3 Year Return
-42.57 %
5 Year Return
0 %

Nuvectis Pharma Inc Stock Fundamentals & Key Indicators

Check Nuvectis Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$240.4M

EPS (TTM)

-1.266

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-188.03%

Nuvectis Pharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nuvectis Pharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$240.4MNANA0.00%
BUY$40.2B114.16%129.828.45%
BUY$109.4B93.97%28.132.94%
NA$32.3BNA117.735.37%
BUY$76.7B42.61%17.6431.41%

Stock Returns calculator for Nuvectis Pharma Inc Stock including INR - Dollar returns

The Nuvectis Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Nuvectis Pharma Inc investment value today

Current value as on today

₹96,307

Returns

-₹3,693

(-3.69%)

Returns from Nuvectis Pharma Inc Stock

-₹14,157 (-14.16%)

Dollar Impact

₹10,463 (+10.46%)

Analyst Recommendation on Nuvectis Pharma Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Nuvectis Pharma Inc. Average target price of $16.8

Nuvectis Pharma Inc Share Price Target

Get share price movements and forecasts by analysts on Nuvectis Pharma Inc.

What analysts predicted

49.11%UPSIDE

Target Price

$16.8

Current Price

$8.55

Analyzed by

9 Analysts

Target

$16.80

Nuvectis Pharma Inc target price $16.8, a slight upside of 49.11% compared to current price of $8.55. According to 9 analysts rating.

Nuvectis Pharma Inc Stock’s Investor Sentiment and Interest

Search interest for Nuvectis Pharma Inc Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Nuvectis Pharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-4
-
-
-
26
-
-
-
-
Gross Profit
-6
-15
-4
-4
-4
13
-
-
-
-
Operating Income
-6
-6
-4
-4
-4
-6
-5
-6
-7
-7
EBITDA
-6
-6
-4
-4
-4
-6
-5
-6
-7
-8
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-5
-6
-4
-4
-4
-6
-5
-6
-7
-7
Income Tax Expense
6
0
0
-
-
-
-
-
-
-
Net Income
-5
-6
-4
-4
-4
-6
-5
-6
-7
-7
Net Profit Margin
0.00%
161.47%
0.00%
0.00%
0.00%
-23.32%
0.00%
0.00%
0.00%
0.00%

Nuvectis Pharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
-
-
-
Gross Profit
-12
-19
-22
-
-
Operating Income
-12
-19
-22
-19
-27
EBITDA
-12
-18
-22
-19
-27
Interest Expense
0
0
-
-
-
Depreciation
-
-
-
-
-
Income Before Tax
-12
-19
-22
-19
-26
Income Tax Expense
0
0
0
-19
-
Net Income
-12
-18
-22
-19
-26
Net Profit Margin
0.00%
-12608.72%
0.00%
0.00%
0.00%

Nuvectis Pharma Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-4
-4
-4
-6
-5
-6
-9
-7
Operating Cash Flow
-3
-4
-3
-2
-2
-4
-3
-4
-3
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
4
1
1
3
15
0
13
0
Change in Cash
-2
0
-1
0
1
11
-3
8
-3

Nuvectis Pharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-19
-22
-19
-26
Operating Cash Flow
-9
-13
-15
-12
-16
Investing Cash Flow
-
-
-
-
-
Financing Cash Flow
15
27
15
11
29
Change in Cash
5
14
0
0
13

Global Institutional Holdings in Nuvectis Pharma Inc

Funds
Holdings
Royal Bank of Canada
0.12%
Austin Wealth Management LLC
0.08%
Barclays PLC
0.07%
Nuveen, LLC
0.06%
State Street Corp
0.58%

Insights on Nuvectis Pharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, NVCT stock has moved up by 28.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Nuvectis Pharma Inc has experienced a drawdown of -42.6%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 28.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 14.6% return, outperforming this stock by 29.3%

About Nuvectis Pharma Inc

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
OrganisationNuvectis Pharma Inc
Headquarters1 Bridge Plaza, Fort Lee, NJ, United States, 07024
IndustryBiotechnology
CEOMr. Ron Bentsur M.B.A.
E-voting on sharesClick here to vote

Key Management of Nuvectis Pharma Inc

Name

Title

Mr. Ron Bentsur M.B.A.

Co-Founder, Chairman, CEO & President

Dr. Enrique Poradosu Ph.D.

Co-Founder, Executive VP, Chief Scientific & Business Officer

Mr. Shay Shemesh

Co-Founder, Executive VP, Chief Development & Operations Officer

FAQs

What is Nuvectis Pharma Inc share price today?

Nuvectis Pharma Inc share price today is $8.55 as on at the close of the market. Nuvectis Pharma Inc share today touched a day high of $8.64 and a low of $8.42.

What is the 52 week high and 52 week low for Nuvectis Pharma Inc share?

Nuvectis Pharma Inc share touched a 52 week high of $11.15 on and a 52 week low of $5.55 on . Nuvectis Pharma Inc stock price today i.e. is closed at $8.55,which is 23.32% down from its 52 week high and 54.05% up from its 52 week low.

What is Nuvectis Pharma Inc's market capitalisation today?

Nuvectis Pharma Inc market capitalisation is $0.00T as on .

How to invest in Nuvectis Pharma Inc Stock (NVCT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nuvectis Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nuvectis Pharma Inc Shares that will get you 0.1754 shares as per Nuvectis Pharma Inc share price of $8.55 per share as on May 1, 2026 at 1:29 am IST.

What is the minimum amount required to buy Nuvectis Pharma Inc Stock (NVCT) from India?

Indian investors can start investing in Nuvectis Pharma Inc (NVCT) shares with as little as ₹94.91 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Nuvectis Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Nuvectis Pharma Inc share’s latest price of $8.55 as on May 1, 2026 at 1:29 am IST, you will get 1.1696 shares of Nuvectis Pharma Inc. Learn more about fractional shares .